In gliomas, increased hBCATc and hBCATm expression has been limited to gliomas with wild-type isocitrate dehydrogenase 1 (IDH1), cytosolic and IDH2, mitochondrial [17, 18]. This evidence concerns the gene IDH2 and central nervous system cancer.